Delia S West1, T Elaine Prewitt, Zoran Bursac, Holly C Felix. 1. Department of Health Behavior and Health Education, University of Arkansas for Medical Sciences, Fay W. Boozman College of Public Health, Little Rock, Arkansas, USA. WestDelia@uams.edu
Abstract
OBJECTIVE: To provide the specific weight loss outcomes for African-American, Hispanic, and white men and women in the lifestyle and metformin treatment arms of the Diabetes Prevention Program (DPP) by race-gender group to facilitate researchers translating similar interventions to minority populations, as well as provide realistic weight loss expectations for clinicians. METHODS AND PROCEDURES: Secondary analyses of weight loss of 2,921 overweight participants (22% black; 17% Hispanic; 61% white; and 68% women) with impaired glucose tolerance randomized in the DPP to intensive lifestyle modification, metformin or placebo. Data over a 30-month period are examined for comparability across treatment arms by race and gender. RESULTS: Within lifestyle treatment, all race-gender groups lost comparable amounts of weight with the exception of black women who exhibited significantly smaller weight losses (P < 0.01). For example, at 12 months, weight losses for white men (-8.4%), white women (-8.1%), Hispanic men (-7.8%), Hispanic women (-7.1%), and black men (-7.1%) were similar and significantly higher than black women (-4.5%). In contrast, within metformin treatment, all race-gender groups including black women lost similar amounts of weight. Race-genderspecific mean weight loss data are provided by treatment arm for each follow-up period. DISCUSSION: Diminished weight losses were apparent among black women in comparison with other race-gender groups in a lifestyle intervention but not metformin, underscoring the critical nature of examining sociocultural and environmental contributors to successful lifestyle intervention for black women.
RCT Entities:
OBJECTIVE: To provide the specific weight loss outcomes for African-American, Hispanic, and white men and women in the lifestyle and metformin treatment arms of the Diabetes Prevention Program (DPP) by race-gender group to facilitate researchers translating similar interventions to minority populations, as well as provide realistic weight loss expectations for clinicians. METHODS AND PROCEDURES: Secondary analyses of weight loss of 2,921 overweight participants (22% black; 17% Hispanic; 61% white; and 68% women) with impaired glucose tolerance randomized in the DPP to intensive lifestyle modification, metformin or placebo. Data over a 30-month period are examined for comparability across treatment arms by race and gender. RESULTS: Within lifestyle treatment, all race-gender groups lost comparable amounts of weight with the exception of black women who exhibited significantly smaller weight losses (P < 0.01). For example, at 12 months, weight losses for white men (-8.4%), white women (-8.1%), Hispanic men (-7.8%), Hispanic women (-7.1%), and black men (-7.1%) were similar and significantly higher than black women (-4.5%). In contrast, within metformin treatment, all race-gender groups including black women lost similar amounts of weight. Race-gender specific mean weight loss data are provided by treatment arm for each follow-up period. DISCUSSION: Diminished weight losses were apparent among black women in comparison with other race-gender groups in a lifestyle intervention but not metformin, underscoring the critical nature of examining sociocultural and environmental contributors to successful lifestyle intervention for black women.
Authors: M L Fitzgibbon; L M Tussing-Humphreys; J S Porter; I K Martin; A Odoms-Young; L K Sharp Journal: Obes Rev Date: 2011-11-10 Impact factor: 9.213
Authors: Clifford R Weiss; Godwin O Abiola; Aaron M Fischman; Lawrence J Cheskin; Jay Vairavamurthy; Brian P Holly; Olaguoke Akinwande; Franklin Nwoke; Kalyan Paudel; Stephen Belmustakov; Kelvin Hong; Rahul S Patel; Eun J Shin; Kimberley E Steele; Timothy H Moran; Richard E Thompson; Taylor Dunklin; Harvey Ziessman; Dara L Kraitchman; Aravind Arepally Journal: Radiology Date: 2019-04-02 Impact factor: 11.105
Authors: Cynthia R Davis; Eric Dearing; Nicole Usher; Sarah Trifiletti; Lesya Zaichenko; Elizabeth Ollen; Mary T Brinkoetter; Cindy Crowell-Doom; Kyoung Joung; Kyung Hee Park; Christos S Mantzoros; Judith A Crowell Journal: Metabolism Date: 2013-11-07 Impact factor: 8.694
Authors: Valerie H Myers; Megan A McVay; Catherine M Champagne; Jack F Hollis; Janelle W Coughlin; Kristine L Funk; Christina M Gullion; Gerald J Jerome; Catherine M Loria; Carmen D Samuel-Hodge; Victor J Stevens; Laura P Svetkey; Phillip J Brantley Journal: J Behav Med Date: 2012-08-21